big4bio-logo-boston-2019-250

The Boston biomedical cluster includes 1000+ companies and is supported by research at leading universities and academic research centers; Kendall Square alone is home to more than 120 life science companies.

The sector has been encouraged through the investment of private and public capital, including the $1B commitment of the 2008 Massachusetts Life Sciences Act. Keep up with every development: Subscribe FREE to Big4Bio:Boston.

Subscribe
Subscribe

EVENT CENTER

sf-events
Boston is #1 when it comes to the number – and the quality — of events held here. Check out our event listings:

SPOTLIGHT

iStock_000008190739Small

Spotlight Q&A: TFF Pharmaceuticals – Innovative Drug Formulation May Expand Geographic Reach of COVID-19 Vaccines and Treatments

LaVoieHealthScience Client Spotlight Following is a Q&A with Glenn Mattes, President, CEO and Director of TFF Pharmaceuticals (Nasdaq: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform. Welcome to Big4Bio, Mr. Mattes. Can you share with our readers what is important about […]

Read More

SPONSORS

iStock_000014574578Large
Check out our regional sponsors and partners – they are leaders in their fields, and we thank them for their support!

SOCIAL MEDIA

twitter-292994_640
We provide even more information by aggregating industry-related videos, podcasts, and more with our social channels: